FDA Inspection 1281728 — Lexington Cln IRB #1
The FDA completed an inspection of Lexington Cln IRB #1 on September 8, 2025 in Lexington, KY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 8, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Lexington, KY (United States)
Additional Details
IRB